CNS Pharmaceuticals ( NASDAQ: CNSP ) announced that it will sell 568,000 shares of common stock in a registered direct offering and warrants to purchase up to 568,000 shares in a concurrent private placement at a combined purchase price of $2.45 apiece. Shares in the company slumped 33% in premarket trade.
The firm added that the warrants issued will have an exercise price of $2.32 per share. The company expects to raise ~$1.
39 million. More on CNS Pharmaceuticals CNS Pharmaceuticals drops 6%, prices $1.37M offering Financial information for CNS Pharmaceuticals.
